ZYNE stock has been making big moves this year and has gained almost 430% since the year began. In fact, Zynerba Pharmaceuticals (NASADAQ:ZYNE)’s stock has doubled over the past month alone amid a couple of big developments.
So why such a big rally? Let’s take a look at the company’s recent big developments
Fast Track Designation for ZygelThe biggest news for ZYNE stock investors was on May 06, when the FDA had granted Zygel, Zynerba’s CBD gel, a Fast Track Designation in treating Fragile X Syndrome.
Fast Track Designation for the ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.